StockData
Takeda Pharmaceutical Co Ltd logo

Takeda Pharmaceutical Co Ltd (TAK) stock

TAKNYSEPharmaceutical PreparationsAlso trades as TKPHF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Jun 17, 2026Score 5/30
$21.64+0.05 (+0.23%)

Close on Nov 17, 2026Market cap $74.58BP/E –Yield –

Takeda Pharmaceutical ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2026 it was ¥727.34B, down 34.1% from the year before. The highest annual figure on record is ¥1.15T in fiscal 2023.

Annual ebitda

PeriodPeriod endValueChange
FY2026Mar 31, 2026¥727.34B-34.1%
FY2025Mar 31, 2025¥1.10T+17.2%
FY2024Mar 31, 2024¥942.08B-18.4%
FY2023Mar 31, 2023¥1.15T+10.6%
FY2022Mar 31, 2022¥1.04T-2.3%
FY2021Mar 31, 2021¥1.07T+56.3%
FY2020Mar 31, 2020¥684.06B+40.9%
FY2019Mar 31, 2019¥485.38B+14.5%
FY2018Mar 31, 2018¥423.92B+29.5%
FY2017Mar 31, 2017¥327.29B–

More Takeda Pharmaceutical figures

See a number that looks wrong?